5 months ago
FBIO
AnalystsScott HenryScott Henry's Stock Forecasts
AnalystsScott Henry
Analyst Ranking
Bottom 11%
#4071 out of 4565 analysts
Average Return
-6.07%
Win Rate
29%12 out of 42
Risk vs Reward
Poor
Good
Scott Henry's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Viking Therapeutics IncVKTX | +342.60% | $2.77 | $12.26 | 2017-11-20 - 2018-11-21 | Strong Buy |
Viking Therapeutics IncVKTX | +221.03% | $21.45 | $68.86 | 2023-05-02 - 2024-04-25 | Strong Buy |
Sensus Healthcare IncSRTS | +133.48% | $4.57 | $10.67 | 2021-02-25 - 2022-02-25 | Strong Buy |
Myomo IncMYO | +81.64% | $5.72 | $10.39 | 2020-11-10 - 2021-11-10 | Strong Buy |
Catalyst Pharmaceuticals IncCPRX | +75.53% | $4.21 | $7.39 | 2021-03-17 - 2022-03-17 | Strong Buy |
Scott Henry Analyst Color
Get additional color on Scott Henry's coverage of popular stocks
Scott Henry's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Journey Medical CorpDERM | 2 | Strong Buy | $8.50 | +142.86% | Initiates Coverage On | 2 months ago |
Renovorx IncRNXT | 3 | Strong Buy | $4.00 | +230.58% | Initiates Coverage On | 3 months ago |
Prosomnus IncOSAP | 3 | Strong Buy | $2.00 | +325.53% | Initiates Coverage On | 3 months ago |
Fortress Biotech IncFBIO | 1 | Strong Buy | $15.00 | +772.09% | Maintains | 5 months ago |
Reviva Pharmaceuticals Holdings IncRVPH | 2 | Strong Buy | $12.00 | +302.68% | Reiterates | 6 months ago |
Champions Oncology IncCSBR | 2 | Strong Buy | $7.50 | +48.22% | Maintains | 7 months ago |
Delcath Systems IncDCTH | 3 | Strong Buy | $13.00 | +147.15% | Maintains | 8 months ago |
Viking Therapeutics IncVKTX | 2 | Strong Buy | $24.00 | -65.15% | Maintains | a year ago |
Assure Holdings CorpIONM | 2 | Strong Buy | $12.00 | N/A | Maintains | a year ago |
Ligand Pharmaceuticals IncLGND | 7 | Strong Buy | $90.00 | N/A | Maintains | a year ago |
Catalyst Pharmaceuticals IncCPRX | 2 | Hold | $15.50 | N/A | Downgrades | 2 years ago |
Invo Bioscience IncINVO | 2 | Hold | $40.00 | N/A | Downgrades | 2 years ago |
Lannett Co IncLCINQ | 4 | Hold | $24.00 | N/A | Maintains | 3 years ago |
Vivos Therapeutics IncVVOS | 3 | Strong Buy | $250.00 | N/A | Maintains | 3 years ago |
Lemaitre Vascular IncLMAT | 1 | Hold | $58.00 | N/A | Maintains | 3 years ago |
Iradimed CorpIRMD | 1 | Strong Buy | $36.00 | N/A | Maintains | 3 years ago |
Soliton IncSOLY | 1 | Hold | N/A | N/A | Downgrades | 3 years ago |
Iridex CorpIRIX | 2 | Strong Buy | $9.00 | N/A | Maintains | 3 years ago |
Sensus Healthcare IncSRTS | 1 | Strong Buy | $6.00 | N/A | Maintains | 3 years ago |
Inmed Pharmaceuticals IncINM | 1 | Strong Buy | $287.50 | N/A | Maintains | 3 years ago |
Myomo IncMYO | 2 | Strong Buy | $7.00 | N/A | Upgrades | 3 years ago |
Q Biomed IncQBIO | 1 | Hold | $1.85 | N/A | Downgrades | 5 years ago |
Neuroderm LtdNDRM | 1 | Hold | N/A | N/A | Downgrades | 7 years ago |
Novabay Pharmaceuticals IncNBY | 1 | Strong Buy | $192.50 | N/A | Initiates Coverage On | 7 years ago |
Tonix Pharmaceuticals Holding CorpTNXP | 1 | Strong Buy | $272,000.00 | N/A | Initiates Coverage On | 11 years ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.